HRP20240798T1 - Terapija matičnim stanicama kod patologija endometrija - Google Patents
Terapija matičnim stanicama kod patologija endometrija Download PDFInfo
- Publication number
- HRP20240798T1 HRP20240798T1 HRP20240798TT HRP20240798T HRP20240798T1 HR P20240798 T1 HRP20240798 T1 HR P20240798T1 HR P20240798T T HRP20240798T T HR P20240798TT HR P20240798 T HRP20240798 T HR P20240798T HR P20240798 T1 HRP20240798 T1 HR P20240798T1
- Authority
- HR
- Croatia
- Prior art keywords
- isolated
- subject
- bmdsc
- use according
- bmdscs
- Prior art date
Links
- 230000002357 endometrial effect Effects 0.000 title claims 3
- 230000007170 pathology Effects 0.000 title 1
- 238000009168 stem cell therapy Methods 0.000 title 1
- 238000009580 stem-cell therapy Methods 0.000 title 1
- 210000001185 bone marrow Anatomy 0.000 claims 3
- 210000005259 peripheral blood Anatomy 0.000 claims 3
- 239000011886 peripheral blood Substances 0.000 claims 3
- 206010051909 Endometrial atrophy Diseases 0.000 claims 2
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 claims 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 230000001483 mobilizing effect Effects 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 210000000685 uterine artery Anatomy 0.000 claims 2
- 201000000736 Amenorrhea Diseases 0.000 claims 1
- 206010001928 Amenorrhoea Diseases 0.000 claims 1
- 206010055690 Foetal death Diseases 0.000 claims 1
- 208000002777 Gynatresia Diseases 0.000 claims 1
- 206010021033 Hypomenorrhoea Diseases 0.000 claims 1
- 208000037093 Menstruation Disturbances Diseases 0.000 claims 1
- 208000035175 Oligomenorrhea Diseases 0.000 claims 1
- 206010030295 Oligomenorrhoea Diseases 0.000 claims 1
- 231100000540 amenorrhea Toxicity 0.000 claims 1
- 238000002617 apheresis Methods 0.000 claims 1
- 210000002565 arteriole Anatomy 0.000 claims 1
- 230000032692 embryo implantation Effects 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- 239000011159 matrix material Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 230000008929 regeneration Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462013121P | 2014-06-17 | 2014-06-17 | |
| EP22150013.5A EP4012023B1 (en) | 2014-06-17 | 2015-06-05 | Stem cell therapy in endometrial pathologies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20240798T1 true HRP20240798T1 (hr) | 2024-09-27 |
Family
ID=54329860
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20240798TT HRP20240798T1 (hr) | 2014-06-17 | 2015-06-05 | Terapija matičnim stanicama kod patologija endometrija |
| HRP20220419TT HRP20220419T1 (hr) | 2014-06-17 | 2015-06-05 | Terapija matičnim stanicama kod patologija endometrija |
| HRP20191240 HRP20191240T1 (hr) | 2014-06-17 | 2015-06-05 | Terapija matičnim stanicama kod patologija endometrija |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20220419TT HRP20220419T1 (hr) | 2014-06-17 | 2015-06-05 | Terapija matičnim stanicama kod patologija endometrija |
| HRP20191240 HRP20191240T1 (hr) | 2014-06-17 | 2015-06-05 | Terapija matičnim stanicama kod patologija endometrija |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US11129851B2 (https=) |
| EP (3) | EP4012023B1 (https=) |
| JP (2) | JP6920062B2 (https=) |
| CN (2) | CN107073040A (https=) |
| AU (1) | AU2015275798B2 (https=) |
| BR (1) | BR112016029558A2 (https=) |
| CA (1) | CA2952559C (https=) |
| CY (2) | CY1122615T1 (https=) |
| DK (2) | DK3569697T3 (https=) |
| ES (3) | ES2983444T3 (https=) |
| HR (3) | HRP20240798T1 (https=) |
| HU (3) | HUE044823T2 (https=) |
| LT (2) | LT3569697T (https=) |
| MX (1) | MX377300B (https=) |
| PL (3) | PL3569697T3 (https=) |
| PT (2) | PT3569697T (https=) |
| RS (3) | RS63093B1 (https=) |
| RU (1) | RU2725006C2 (https=) |
| SI (2) | SI3158057T1 (https=) |
| SM (3) | SMT201900400T1 (https=) |
| TR (1) | TR201910410T4 (https=) |
| WO (1) | WO2015193737A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| EP3467124A1 (en) | 2012-06-06 | 2019-04-10 | Fundació Institut de Recerca Biomèdica IRB (Barcelona) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis |
| US10119171B2 (en) | 2012-10-12 | 2018-11-06 | Inbiomotion S.L. | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis |
| KR101872965B1 (ko) | 2012-10-12 | 2018-06-29 | 인바이오모션 에스.엘. | Ｃ―ｍａｆ를 이용하는 전립선암 전이의 진단, 예후 및 치료 방법 |
| CA2903306A1 (en) | 2013-03-15 | 2014-09-18 | Fundacio Institut De Recerca Biomedica (Irb Barcelona) | Method for the diagnosis, prognosis and treatment of metastatic cancer |
| US11129851B2 (en) | 2014-06-17 | 2021-09-28 | Igenomix S.L. | Stem cell therapy in endometrial pathologies |
| JP7637323B2 (ja) * | 2016-06-23 | 2025-02-28 | ティソン バイオテック，インコーポレイテッド | 副甲状腺ホルモン１型受容体を発現する細胞およびその使用 |
| RU2699029C1 (ru) * | 2018-12-10 | 2019-09-03 | Частное образовательное учреждение дополнительного профессионального образования "Академия медицинского образования имени Федора Ивановича Иноземцева" (ЧОУ ДПО "Академия медицинского образования им. Ф.И. Иноземцева") | Способ использования мезенхимальных стволовых клеток для улучшения состояния рубца на матке |
| RU2741621C1 (ru) * | 2020-09-25 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр акушерства, гинекологии и перинатологии имени академика В.И. Кулакова" Министерства здравоохранения Российской Федерации | Способ лечения внутриматочных синехий |
| WO2023003130A1 (ko) | 2021-07-23 | 2023-01-26 | 차의과학대학교 산학협력단 | 분리된 미토콘드리아를 유효성분으로 포함하는 아셔만 증후군 예방 또는 치료용 약학 조성물 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE140868T1 (de) | 1989-05-05 | 1996-08-15 | North Sydney Area Health Serv | Steigerung der fruchtbarkeit |
| US6979533B2 (en) | 1992-06-12 | 2005-12-27 | The Trustees Of The University Of Pennsylvania | Determination of endometrial receptivity toward embryo implantation |
| CA2203718A1 (en) | 1997-04-25 | 1998-10-25 | University Of British Columbia | Cadherin-11 as an indicator of viable pregnancy |
| IL127896A0 (en) | 1998-12-31 | 1999-10-28 | Gail Laster | A novel treatment for preeclampsia and related diseases |
| AU2001240096A1 (en) | 2000-03-08 | 2001-09-17 | Rebecca L. Dubowy | Methods of diagnosing and monitoring endometrial glandular development |
| AU2001264900A1 (en) | 2000-05-24 | 2001-12-03 | Schering Aktiengesellschaft | Pharmaceutical use of fibulin-1 |
| US6780594B2 (en) | 2000-09-25 | 2004-08-24 | Schering Aktiengesellschaft | Method for in vitro diagnosis of endometriosis |
| AUPR673001A0 (en) | 2001-07-31 | 2001-08-23 | Prince Henry's Institute Of Medical Research | Pregnancy-related enzyme activity |
| DE10139874A1 (de) | 2001-08-10 | 2003-04-30 | Schering Ag | Humane Mater-Proteine |
| GB0201284D0 (en) | 2002-01-21 | 2002-03-06 | Isis Innovation | Screening methods for contraceptive and fertility agents |
| US20030186300A1 (en) | 2002-03-20 | 2003-10-02 | Ali Akoum | Methods and products for modulation of reproductive processes and for diagnosis, prognostication and treatment of related conditions |
| EP1511863A4 (en) | 2002-05-14 | 2006-12-27 | Univ Leland Stanford Junior | ENDOMETRIAL GENES FOR THE DETECTION OF ENDOMETRIAL DISORDERS |
| DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
| ES2273061T3 (es) | 2002-08-02 | 2007-05-01 | Schering Aktiengesellschaft | Agentes moduladores de receptores de progesterona con actividad antigonadotropa elevada para el control de fertilidad femenina y para la terapia por reemplazo hormonal. |
| US20060292567A1 (en) | 2002-12-21 | 2006-12-28 | Universitat Leipzig | Method and means for determining specific conditions or changes in the uterine epithelium and in the epithelium of other organs |
| US20060286555A1 (en) | 2003-08-21 | 2006-12-21 | Van Beuningen Marinus G J | Microarray support for bioprobe synthesis |
| WO2005026324A2 (en) | 2003-09-08 | 2005-03-24 | The Board Of Regents Of The University Of Texas System | Method and composition for enhancing in vitro embryo development by supplementing culture medium with prostaglandin or a prostaglandin analog |
| CN1863905A (zh) | 2003-09-08 | 2006-11-15 | 得克萨斯系统大学董事会 | 通过用前列腺素或前列腺素类似物补充培养基加强体外胚发育的方法以及组合物 |
| CA2550900A1 (en) | 2003-12-23 | 2005-07-07 | Mount Sinai Hospital | Methods for detecting markers associated with endometrial disease or phase |
| EP1765083A4 (en) | 2004-05-28 | 2008-08-20 | Serono Lab | USE OF IL-17 TO TREAT FERTILITY DISORDERS |
| JP2009531705A (ja) * | 2006-03-31 | 2009-09-03 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 超短ｔ２＊緩和測定法を用いた細胞測定のためのシステムおよび方法 |
| JP2007278750A (ja) | 2006-04-04 | 2007-10-25 | Ono Pharmaceut Co Ltd | プロスタグランジン類及びその類縁体の定量方法 |
| WO2008036374A2 (en) * | 2006-09-21 | 2008-03-27 | Medistem Laboratories, Inc. | Allogeneic stem cell transplants in non-conditioned recipients |
| GB0703683D0 (en) * | 2007-02-26 | 2007-04-04 | Ark Therapeutics Ltd | The treatment of complications in pregnancy |
| US9259233B2 (en) * | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
| WO2009143633A1 (en) | 2008-05-30 | 2009-12-03 | Institut De Recherches Cliniques De Montreal | Pcsk9 inhibitors and methods of use thereof |
| WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
| WO2013166281A1 (en) * | 2012-05-02 | 2013-11-07 | Cedars-Sinai Medical Center | Bi-functional compositions for targeting cells to diseased tissues and methods of using same |
| EP2348318A1 (en) | 2010-01-21 | 2011-07-27 | Equipo Ivi Investigación, S.L. | Diagnostic method for endometrial receptivity |
| EP2768976B1 (en) | 2011-10-21 | 2018-01-10 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation |
| US9423402B2 (en) | 2011-11-30 | 2016-08-23 | Singapore Health Services Pte. Ltd. | GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring |
| MX356775B (es) | 2012-06-27 | 2018-06-13 | Hoffmann La Roche | Medios y metodos que aplican sflt-1/plgf o relacion de endoglina/plgf para descartar el inicio de preeclampsia en un determinado periodo de tiempo. |
| RU2515475C1 (ru) | 2012-11-15 | 2014-05-10 | Федеральное государственное бюджетное учреждение науки ИНСТИТУТ ЦИТОЛОГИИ РОССИЙСКОЙ АКАДЕМИИ НАУК | Способ стимуляции образования децидуальной оболочки эндометрия в эксперименте |
| JP6684263B2 (ja) | 2014-03-21 | 2020-04-22 | アイジェノミクス エセ．エレ． | 子癇前症の早期検出 |
| US11129851B2 (en) | 2014-06-17 | 2021-09-28 | Igenomix S.L. | Stem cell therapy in endometrial pathologies |
-
2015
- 2015-06-05 US US15/318,825 patent/US11129851B2/en active Active
- 2015-06-05 SI SI201530822T patent/SI3158057T1/sl unknown
- 2015-06-05 MX MX2016016756A patent/MX377300B/es active IP Right Grant
- 2015-06-05 SM SM20190400T patent/SMT201900400T1/it unknown
- 2015-06-05 JP JP2016573587A patent/JP6920062B2/ja active Active
- 2015-06-05 HU HUE15781411 patent/HUE044823T2/hu unknown
- 2015-06-05 HR HRP20240798TT patent/HRP20240798T1/hr unknown
- 2015-06-05 PT PT191693092T patent/PT3569697T/pt unknown
- 2015-06-05 HR HRP20220419TT patent/HRP20220419T1/hr unknown
- 2015-06-05 CN CN201580043147.1A patent/CN107073040A/zh active Pending
- 2015-06-05 SM SM20220155T patent/SMT202200155T1/it unknown
- 2015-06-05 DK DK19169309.2T patent/DK3569697T3/da active
- 2015-06-05 RS RS20220339A patent/RS63093B1/sr unknown
- 2015-06-05 LT LTEP19169309.2T patent/LT3569697T/lt unknown
- 2015-06-05 ES ES22150013T patent/ES2983444T3/es active Active
- 2015-06-05 RU RU2017101147A patent/RU2725006C2/ru active
- 2015-06-05 SM SM20240270T patent/SMT202400270T1/it unknown
- 2015-06-05 AU AU2015275798A patent/AU2015275798B2/en active Active
- 2015-06-05 PL PL19169309T patent/PL3569697T3/pl unknown
- 2015-06-05 PL PL22150013.5T patent/PL4012023T3/pl unknown
- 2015-06-05 HR HRP20191240 patent/HRP20191240T1/hr unknown
- 2015-06-05 HU HUE19169309A patent/HUE058328T2/hu unknown
- 2015-06-05 ES ES19169309T patent/ES2910306T3/es active Active
- 2015-06-05 DK DK15781411.2T patent/DK3158057T3/da active
- 2015-06-05 RS RSP20190913 patent/RS59210B1/sr unknown
- 2015-06-05 EP EP22150013.5A patent/EP4012023B1/en active Active
- 2015-06-05 PL PL15781411T patent/PL3158057T3/pl unknown
- 2015-06-05 TR TR2019/10410T patent/TR201910410T4/tr unknown
- 2015-06-05 EP EP15781411.2A patent/EP3158057B1/en active Active
- 2015-06-05 BR BR112016029558A patent/BR112016029558A2/pt not_active Application Discontinuation
- 2015-06-05 ES ES15781411T patent/ES2736117T3/es active Active
- 2015-06-05 CN CN202310575540.1A patent/CN116747241A/zh active Pending
- 2015-06-05 PT PT15781411T patent/PT3158057T/pt unknown
- 2015-06-05 SI SI201531822T patent/SI3569697T1/sl unknown
- 2015-06-05 WO PCT/IB2015/001715 patent/WO2015193737A1/en not_active Ceased
- 2015-06-05 EP EP19169309.2A patent/EP3569697B8/en active Active
- 2015-06-05 HU HUE22150013A patent/HUE067463T2/hu unknown
- 2015-06-05 RS RS20240690A patent/RS65719B1/sr unknown
- 2015-06-05 CA CA2952559A patent/CA2952559C/en active Active
- 2015-06-05 LT LTEP15781411.2T patent/LT3158057T/lt unknown
-
2019
- 2019-07-16 CY CY20191100753T patent/CY1122615T1/el unknown
-
2020
- 2020-06-12 JP JP2020102340A patent/JP2020138984A/ja active Pending
-
2022
- 2022-04-05 CY CY20221100258T patent/CY1125938T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20240798T1 (hr) | Terapija matičnim stanicama kod patologija endometrija | |
| Wakefield et al. | Scleritis: immunopathogenesis and molecular basis for therapy | |
| MX2022006107A (es) | Metodos y composiciones para dosificacion en terapia celular adoptiva. | |
| MX2009006786A (es) | Composiciones y metodos para el tratamiento de infecciones y tumores. | |
| JP2015131795A5 (https=) | ||
| JP2017522288A5 (https=) | ||
| WO2017066136A3 (en) | Antibody agents specific for human cd19 and uses thereof | |
| MX2016010683A (es) | Terapia para tratar enfermedades mediante la induccion de respuesta inmune de las células que expresan trop-2. | |
| HN2011001195A (es) | Compuestos que expanden las celulas madre hematopoieticas | |
| MX366317B (es) | Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias. | |
| MX377340B (es) | Composiciones en solución sólida y uso en el tratamiento de enfermedades cardiovasculares. | |
| UY37967A (es) | Compuestos y métodos para la reducción de la expresión de snca | |
| CO2020006443A2 (es) | Métodos y composiciones para la dosificación de células t con receptor de antígeno quimérico alogénicas | |
| TN2017000270A1 (en) | Use of prg4 as an anti-inflammatory agent | |
| MX2016000063A (es) | Matriz de cromatografia de afinidad. | |
| MX2017014294A (es) | Metodos y composiciones para el diagnostico y el tratamiento de trastornos en pacientes con elevados niveles de cxcl9 y otros biomarcadores. | |
| ES2421717T3 (es) | Fosfatasa alcalina para aumentar la actividad del sistema inmune en un mamífero con riesgo de enfermedades inflamatorias | |
| MX2019009190A (es) | Uso de gaboxadol en el tratamiento de tinnitus. | |
| EA201690323A1 (ru) | Способы лечения заболеваний уха у детей | |
| BR112017005713A2 (pt) | composto da fórmula (i), método de mobilização das células-tronco hematopoiéticas (hsc) e células progenitoras endoteliais (epc) na circulação periférica, método de tratamento de lesão tecidual, câncer, doença inflamatória ou doença autoimune, e composição farmacêutica | |
| MX2025001934A (es) | UN ANTICUERPO HUMANIZADO QUE TIENE ESPECIFICIDAD DE UNIÓN PARA LA INTEGRINA A4ß7 HUMANA PARA USARSE EN LA PREVENCIÓN O REDUCCIÓN DE LA APARICIÓN DE GVHD AGUDA EN UN PACIENTE HUMANO QUE TIENE ALL O AML Y QUE SE SOMETE A ALLO-HSCT | |
| MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
| CR20170470A (es) | Tratamiento de pacientes con diabetes mellitus tipo 2 | |
| MX2017001632A (es) | Mioinositol y probioticos, y uso de estos. | |
| WO2015120436A3 (en) | Stat3 phosphorylation during graft-versus-host disease |